1. (NYSEMKT: XXII) 22ND CENTURY GROUP
Okay, this cannabis stock is one I am a bit biased on. 22nd Century Group is a plant-based biotechnology company, which is working on reducing nicotine levels in tobacco plants as well as THC levels in marijuana. The goal is to make less addictive cigarettes as well as weaker marijuana. The FDA has recently planned to regulate nicotine levels, which could lead to this company growing exponentially.
2. (NYSE: ABBV): ABBVIE INC.
AbbVie is a pharmaceutical company that discovers, develops and markets both biopharmaceuticals and small molecule drugs. It has a cannabis based drug on the market already. Marinol, the drug AbbVie Inc. created, is used to alleviate nausea for chemotherapy patients. Marinol is one of few cannabis-based drugs on the market today.